(Q35156848)

6 August 2017

1 reference

title

Roles of insulin-like growth factor-I and growth hormone in mediating insulin resistance in acromegaly (English)

1 reference

6 August 2017

1 reference

1 reference

David Robert Clemmons

series ordinal

1 reference

6 August 2017

publication date

1 January 2002

1 reference

6 August 2017

1 reference

6 August 2017

1 reference

6 August 2017

1 reference

6 August 2017

page(s)

181-183

1 reference

Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist

6 August 2017

cites work

1 reference

12 December 2020

Energy metabolism and substrate oxidation in acromegaly.

1 reference

12 December 2020

Recombinant human insulin-like growth factor I increases insulin sensitivity and improves glycemic control in type II diabetes

1 reference

12 December 2020

Effects of growth hormone on glucose metabolism

1 reference

12 December 2020

Loss of sensitivity to insulin at early events of the insulin signaling pathway in the liver of growth hormone-transgenic mice

1 reference

12 December 2020

Transgenic rabbits overexpressing growth hormone develop acromegaly and diabetes mellitus.

1 reference

12 December 2020

Impaired beta-cell function in the presence of reduced insulin sensitivity determines glucose tolerance status in acromegalic patients

1 reference

12 December 2020

Role of hyperinsulinemia on hepatic insulin receptor concentration and autophosphorylation in the presence of high growth hormone levels in transgenic mice overexpressing growth hormone gene

1 reference

12 December 2020

Alterations in the early steps of the insulin-signaling system in skeletal muscle of GH-transgenic mice.

1 reference

12 December 2020

Insulin resistance in acromegaly: defects in both hepatic and extrahepatic insulin action.

1 reference

12 December 2020

Long-Term Effect of Octreotide in Acromegaly on Insulin Resistance

1 reference

12 December 2020

Effects of treatment with octreotide in acromegalic patients--a multicenter Italian study. Italian Multicenter Octreotide Study Group

1 reference

12 December 2020

Impact of octreotide, a long-acting somatostatin analogue, on glucose tolerance and insulin sensitivity in acromegaly

1 reference

12 December 2020

Bromocriptine treatment over 12 years in acromegaly: effect on glucose tolerance and insulin secretion.

1 reference

12 December 2020

Acromegaly. Clinical and biochemical features in 500 patients

1 reference

12 December 2020

Growth hormone responses to oral glucose loading measured by highly sensitive enzyme immunoassay in normal subjects and patients with glucose intolerance and acromegaly

1 reference

12 December 2020

Growth hormone-induced insulin resistance: role of the insulin receptor, IRS-1, GLUT-1, and GLUT-4.

1 reference

12 December 2020

Non-insulin-mediated glucose uptake in several insulin-resistant states in the postabsortive period.

1 reference

12 December 2020

Basal- and insulin-stimulated substrate metabolism in patients with active acromegaly before and after adenomectomy

1 reference

12 December 2020

IGF-I/IGF-binding protein-3 combination improves insulin resistance by GH-dependent and independent mechanisms

1 reference

12 December 2020

Peripheral glucose metabolism in acromegaly.

1 reference

12 December 2020

1 reference

12 December 2020

Assessment of insulin resistance in acromegaly associated with diabetes mellitus before and after transsphenoidal adenomectomy

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1023321421760

1 reference

Dimensions Publication ID

6 August 2017

1017919777

0 references

1 reference